Lobbying Relationship

Client

Isis Pharmaceuticals

pharmaceutical research company More records

Lobbying firm

MCDERMOTT WILL & EMERY LLP

More records

  • Health care and patent legislation to ensure the protection of life-saving medical research and development.

Duration: to

General Issues: Health Issues, Medical/Disease Research/Clinical Labs, Pharmacy

Spending: about $385,000 (But it's complicated. Here's why.)

Agencies lobbied since 2010: House of Representatives, U.S. Senate

Bills mentioned

S.23: America Invents Act

Sponsor: Patrick J. Leahy (D-Vt.)

H.R.1249: Leahy-Smith America Invents Act

Sponsor: Lamar Smith (R-Texas)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Stephen M. Ryan 1987-91: Gen Counsel, Govt Affairs Comm, US Senate; 1986: Asst US Attorney, DC; 1984-86: Deputy Counsel, President's Commission on Organized Crime. US Senate; 1986: Asst US Attorney, DC; 1984-86: Deputy Counsel, President's Commission on
David Ransom 2007-08: Sr Communications and Policy Advisor, House Majority Leader Steny Hoyer; 2002-06: Communications Director, House Democratic Whip Steny Hoyer; 1999-2001: Communications Director, House Committee on Administration (Steny Hoyer, Ranking Member). Organized Crime. Advisor, House Majority Leader Steny Hoyer; 2002-06: Communications Director, House Communiations Director, House Committee on Administration (Steny Hoyer, Ranking
Sheila D. Walcoff 2006-07: Counselor to The Honorable Michael O. Leavitt (Immediate Office of the Secretary), U.S. Commissioner for External Relations, U.S. FDA; 1998-99: Majority Counsel, Armed Services Committee, U.S. House of Representatives. 1987-91: Gen Counsel, Govt Affairs Comm US Senate; 1986: Asst US Attorney, DC. Michael O. Leavitt (Immediate Office of the Secretary), 2004-06: Associate Commissioner for External Relations, U.S. FDA; 1998-99: Majority Counsel, 2006-07: Counselor to The Honorable
David Ramsom Member)
Sheila Walcoff 2006-07: Counselor to The Honorable
Karen Sealander n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Registration
Termination
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page